Skip to content

Tackling Counterfeit Drugs in the Global Pharma Supply Chain

Global sales for counterfeit drugs cost businesses billions of dollars per year. Drug counterfeiting affects human lives, business reputation, and return on investment for the entire pharmaceutical industry. According to the World Health Organization, it is estimated that up to 30% of pharmaceutical products sold in emerging markets are counterfeit, and about 1 million people

Implementation of a Daml Solution for Optimizing Clinical Trials

Conducting clinical trials is a time consuming and costly process that brings along unique and intrinsic challenges. In a recent blog post, Lakshmi Shastry, Principal Solutions Architect at Brillio, talked about the challenges around the clinical trial process and highlighted the different ways multi-party workflow technology, including key components of Brillio’s solution with Daml, can

How to Streamline and Accelerate Clinical Trials

Conducting clinical trials is a time consuming, expensive affair that involves close collaboration between multiple stakeholders (parties), often geographically distributed, and one that needs a high level of monitoring, regulation, and precision to maintain patient privacy and auditability. In this two-part blog series, Lakshmi Shastry, Principal Solutions Architect at Brillio, explains the challenges around clinical

Improve Pharmaceutical Efficiency and Transparency with Daml Driven Solutions for Supply Chains and Patient Data

Chander Damodaran from Brillio discusses how Daml smart contracts can accelerate the collaboration and automation of multiparty business processes in clinical trials and pharma supply chains As 2021 begins to take flight, the entire world has turned their attention to Moderna, Pfizer-BioNTech, and many other pharmaceutical organizations to slow the spread of COVID-19 and its

Get notified of updates